Taxol and recombinant human granulocyte colony-stimulating factor, an active regimen as initial therapy for metastatic breast cancer. A preliminary report.

Reichman, B S; Seidman, A D; Crown, J P; Heelan, R; Yao, T J; Hakes, T B; Lebwohl, D E; Gilewski, T A; Surbone, A; Currie, V

Reichman, B S; Seidman, A D; Crown, J P; Heelan, R; Yao, T J; Hakes, T B; Lebwohl, D E; Gilewski, T A; Surbone, A; Currie, V.

Affiliation

Reichman BS; Strang-Cornell Breast Center, New York, New York 10021.

Ann N Y Acad Sci ; 698: 398-402, 1993 Nov 30.

Article in En | MEDLINE | ID: mdl-7506506

Subject(s)

Breast Neoplasms/drug therapy; Granulocyte Colony-Stimulating Factor/therapeutic use; Paclitaxel/toxicity; Paclitaxel/therapeutic use; Adult; Aged; Breast Neoplasms/pathology; Female; Humans; Middle Aged; Neoplasm Metastasis; Neutropenia/prevention & control; Recombinant Proteins/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Granulocyte Colony-Stimulating Factor / Paclitaxel Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Ann N Y Acad Sci Year: 1993 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links